---
title: "LUYIN INVEST released its first-quarter performance, with a net profit attributable to shareholders of 79.35 million yuan, a year-on-year decrease of 1.16%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237861638.md"
description: "According to the Zhitong Finance APP, LUYIN INVEST disclosed its first-quarter report for 2025. During the reporting period, the company achieved revenue of 814 million yuan, a year-on-year increase of 0.10%; net profit attributable to the parent company was 79.35 million yuan, a year-on-year decrease of 1.16%; and net profit excluding non-recurring gains and losses was 76.86 million yuan, a year-on-year increase of 1.74%. Basic earnings per share were 0.12 yuan"
datetime: "2025-04-28T13:06:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237861638.md)
  - [en](https://longbridge.com/en/news/237861638.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237861638.md)
generator: "portal-rs"
---

# LUYIN INVEST released its first-quarter performance, with a net profit attributable to shareholders of 79.35 million yuan, a year-on-year decrease of 1.16%

According to the Zhitong Finance APP, LUYIN INVEST (600784.SH) disclosed its first-quarter report for 2025. During the reporting period, the company achieved revenue of 814 million yuan, a year-on-year increase of 0.10%; net profit attributable to shareholders was 79.35 million yuan, a year-on-year decrease of 1.16%; and net profit excluding non-recurring items was 76.86 million yuan, a year-on-year increase of 1.74%. Basic earnings per share were 0.12 yuan

### Related Stocks

- [600784.CN](https://longbridge.com/en/quote/600784.CN.md)

## Related News & Research

- [SOTL: Record revenue, margin expansion, and innovation drive robust growth and future optimism](https://longbridge.com/en/news/297615048.md)
- [Biocytogen licenses fully human VHH antibody to Qilu Pharma in non-exclusive deal](https://longbridge.com/en/news/297781804.md)
- [G Sachs Raises CICC  TP to HKD38.2 on Solid 1H Results](https://longbridge.com/en/news/297620924.md)
- [10:56 ETConsello Opens Brussels Office](https://longbridge.com/en/news/297670112.md)
- [CMA: Gross profit doubled and FY27 revenue is forecast to grow over 80% as scale and margins improve](https://longbridge.com/en/news/297444189.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**